Showing results (171-180 of 365) with videos related to

Sort By:
Pageof 37
Hereditary Cancer in Clinical Practice|January 10, 2019
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of KoreansHakyoung Kim, Doo Ho Choi, Won Park, et al.
Breast Cancer Research and Treatment|July 5, 2021
Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancerJi-Yeon Kim, Eunjoo Jeon, Soonhwan Kwon, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: comparison of korean all-ages group and Western younger age groupIn Gyu Hwang, Keon Hee Yoo, Soo Hyun Lee, et al.
Breast Cancer Research and Treatment|August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trialsManuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
Oncology|September 22, 2011
Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestationsJee Hyun Kong, Yeon Hee Park, Jung A Kim, et al.
Korean Journal of Radiology|April 27, 2025
Surveillance Outcomes by Imaging Methods in the First 5 Years After Breast Cancer SurgeryMyoung Kyoung Kim, Min Su Park, Min Gyu Go, et al.
Asia-Pacific Journal of Clinical Oncology|November 22, 2016
Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapyHakyoung Kim, Won Park, Seung Jae Huh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 11, 2010
Clinical presentation of carcinoma of unknown primary: 14 years of experienceJun Ho Yi, Yoon La Choi, Su Jin Lee, et al.
Breast Cancer Research and Treatment|August 20, 2020
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancerJi-Yeon Kim, Hae Hyun Jung, Insuk Sohn, et al.
Future Oncology (London, England)|November 16, 2022
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancerSara A Hurvitz, Thomas Bachelot, Giampaolo Bianchini, et al.
Pageof 37